VION Biosciences acquires Echelon Biosciences

VION Biosciences has announced the acquisition of Echelon Biosciences, known for its supply of materials such as lipid-based excipients.

Aug 25, 2024 - 04:00

VION Biosciences acquires Echelon Biosciences

VION Biosciences has announced the acquisition of Echelon Biosciences, known for its supply of materials such as lipid-based excipients.

Read the original article

Tags:

Previous Article

Rafael Holdings and Cyclo Therapeutics enter merger deal

FDA approves updated mRNA vaccines for Covid-19

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Activist investor Starboard forges $1bn stake in Pfizer to swing profits

Activist investor Starboard forges $1bn stake in Pfizer...

Oct 8, 2024

Farletuzumab ecteribulin by Eisai for Ovarian Cancer: L...

Apr 23, 2024

Demand for home health aides is soaring. So why are they still so undervalued?

Demand for home health aides is soaring. So why are the...

Apr 15, 2023